Genome&Company
Develops microbiome drugs and novel immune checkpoint inhibitors for immuno-oncology.
314130 | KO
Overview
Corporate Details
- ISIN(s):
- KR7314130006
- LEI:
- Country:
- South Korea
- Address:
- 경기도 수원시 영통구 창룡대로256번길 50 7층, 8층, 수원시
- Website:
- http://genomecom.co.kr/
- Sector:
- Manufacturing
Description
Genome&Company is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapeutics. The company's research and development pipeline is centered on two primary platforms: microbiome-based pharmaceuticals and novel immune checkpoint inhibitors for immuno-oncology. Its drug candidates are derived from its proprietary microbiome platform and are aimed at treating a range of diseases, with a significant focus on cancer. In addition to its pharmaceutical programs, the company develops and markets consumer healthcare products, including dietary supplements and cosmeceuticals, leveraging its expertise in microbes and probiotics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-04-24 00:00 |
주요사항보고서(전환사채권발행결정)
|
Korean | 132.8 KB | ||
| 2025-04-04 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 97.0 KB | ||
| 2025-03-28 00:00 |
정기주주총회결과
|
Korean | 35.3 KB | ||
| 2025-03-28 00:00 |
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 10.8 KB | ||
| 2025-03-28 00:00 |
주식매수선택권부여에관한신고
|
Korean | 16.7 KB | ||
| 2025-03-24 00:00 |
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 9.8 KB | ||
| 2025-03-20 00:00 |
감사보고서제출
|
Korean | 25.0 KB | ||
| 2025-03-20 00:00 |
사업보고서 (2024.12)
|
Korean | 581.6 KB | ||
| 2025-03-13 00:00 |
주주총회소집공고
|
Korean | 347.7 KB | ||
| 2025-03-13 00:00 |
의결권대리행사권유참고서류
|
Korean | 189.1 KB | ||
| 2025-03-12 00:00 |
투자판단관련주요경영사항(임상시험계획자진취하등)
|
Korean | 12.5 KB | ||
| 2025-03-12 00:00 |
주주총회소집결의
|
Korean | 23.4 KB | ||
| 2025-03-12 00:00 |
주주총회집중일개최사유신고
|
Korean | 4.6 KB | ||
| 2025-02-27 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.2 KB | ||
| 2025-02-13 00:00 |
기업설명회(IR)개최
|
Korean | 7.4 KB |
Automate Your Workflow. Get a real-time feed of all Genome&Company filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Genome&Company
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Genome&Company via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
